Clermont-Ferrand, 09 June 2016 – METabolic EXplorer, a biological chemistry company that specialises in developing manufacturing bioprocesses for bio-based compounds used in a wide range of everyday products, including textile fibres, animal feed supplements and resins, is issuing a communication concerning its Annual General Meeting.

The shareholders are informed that the company’s Combined Annual General Meeting convened for 8 June 2016 at the International Airport of Clermont-Ferrand Auvergne, 63510 Aulnat could not be validly held owing to lack of quorum.

Consequently, the shareholders are now being convened on Tuesday 28^th June at 9:30 am to the International Airport of Clermont-Ferrand Auvergne, 63510 Aulnat to rule on the same agenda. A second convening notice will soon be published in the Bulletin des Annonces Légales Obligatoires.

Shareholders who, as part of the convening notice for the Annual General Meeting of 8 June, have already expressed their votes either by postal voting form or proxy form are not required to send a further voting form.

Shareholders who have not voted by post or proxy as part of the first convening notice are invited to send their forms and shareholder certificates by email to infofin@metabolic-explorer.com or by mail to:

CIC c/o CM -CIC TITRES
3, allée de l’Etoile
95014 CERGY- PONTOISE

or by mail directly to the company headquarters:

METabolic EXplorer
Service Assemblée Générale
Biopôle Clermont Limagne
1 rue Emile Duclaux
63360 SAINT-BEAUZIRE.

Shareholders who have attended the meeting of 8 June and who could not attend the next Annual General meeting of 28 june are also invited to send their forms and shareholder certificates.

The text of the agenda and the draft resolutions, which remains unchanged, as well as the new form for the second convening notice are available on the company website, www.metabolic-explorer.com, at Investor Relations > Statutory information > Annual general meetings.

-ENDS-

About METabolic EXplorer- www.metabolic-explorer.com

METabolic EXplorer is a biological chemistry company founded in 1999. Its aim is to harness its biotechnological innovations to contribute to the alternative production of consumer goods in respect of the environment and in response to the new social expectations of consumers.

Based on the tried and tested principle of industrial fermentation, METabolic EXplorer’s solutions replace today’s petrochemical processes with the use of a wide range of plant-based raw materials. By optimizing the metabolic yield of non-pathogenic bacteria in a contained, controlled environment, the company facilitates the production of chemical compounds used in a wide range of everyday goods (textile fibres, plastics, resins, solvents or feed supplements for animal nutrition and health).

METabolic EXplorer is currently focusing its alternative processes on the production of three compounds that together have an estimated, annual, end-market value of €7 billion. The company’s strategy will be implemented through industrial partnerships in the shape of licenses and joint ventures, as well as own-account production units.

METabolic EXplorer, based in Clermont-Ferrand, France, is listed on Euronext in Paris (Compartment C, METEX) and is part of the CAC Small index.

Get free financial information on METabolic EXplorer by registering with:
www.metabolic-explorer.com or www.actus-finance.com

 Media and individual shareholder relations
ATTITUDE Corporate
Eric de Lambert
E-mail: edelambert@attitude-corporate.com
Tél.: +33 (0)6 2529 0658

Investor and analyst relations
ACTUS finance & communication
Jérôme Fabreguettes-Leib
Email :jfl@actus.fr
Tél. : +33 (0)1 5367 3678

Disclaimer
In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.